Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G for Cumberland Pharmaceuticals Inc. Common Stock, no par value (CPIX).
- Disclosed ownership: 4.9%.
- Date of event: 31 Mar 2025.
Ikarian Capital, LLC - 31 Mar 2025 SCHEDULE 13G Report for Cumberland Pharmaceuticals Inc. Common Stock, no par value (CPIX)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- CPIX
- Shares outstanding
- 14,916,980 shares
- Disclosed Ownership
- 730,932 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 17:26:36 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 4.9% ownership in Cumberland Pharmaceuticals Inc. Common Stock, no par value (CPIX) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 17:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 4.9% | 730,932 | 0 | 730,932 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 4.9% | 730,932 | 0 | 730,932 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager |